A local firm is getting a leg up from the government of Quebec in its mission to restore vision to the blind.
Ottawa-based iBIONICS is developing a patented technology that could help blind people to see by capturing visual data with a specialized pair of glasses and sending those electronic signals to the brain through a diamond-based implant in the eye.
The Quebec government announced Thursday the startup will receive a total of $438,400 in financing from the Quebec Life Sciences Strategy. The 10-year, $205-million fund is meant to foster innovation in the province’s health-care system and set firms up to attract private investment down the line.
(Sponsored)
Borden Ladner Gervais LLP and partners lead with generosity
Borden Ladner Gervais LLP (BLG) are no strangers to supporting charities in the nation’s capital. From the Boys & Girls Club of Ottawa to Crohn’s and Colitis Canada to the
How shared goals at Tamarack Ottawa Race Weekend strengthen workplace culture
Across workplaces of all sizes and sectors, organizations are continuing to look for meaningful ways to bring people together. Team connection, employee well-being, and community impact are no longer separate
In a statement, iBIONICS CEO and co-founder Suzanne Grant said the extra cash will set the firm up to raise an equity round later this fall. Coming in to 2018, the firm had raised roughly US$4 million between grants and public and private funding sources.
“If you have a highly-purposed mission within your project, the level of support you get is very different,” Grant told Techopia Live earlier this year.
